PositiveID | GenomeWeb

PositiveID

The company's revenues were primarily derived from a deferred license fee from Boeing, with the remainder coming from the operations of two recent acquisitions.

Proceeds will go toward the further development and field testing of the Firefly DX system and for general working capital. 

The partners will evaluate GenArraytion's MultiFlex assays for clinical, veterinary, food-and water-borne, and weaponized pathogens.

The company's chairman and CEO said that PositiveID has a sizeable backlog and pipeline of revenue opportunities for 2015. 

PositiveID will issue $4 million in senior secured convertible promissory notes to institutional investor Dominion Capital, the firm announced today.

NEW YORK (GenomeWeb) – PositiveID today announced an agreement with the US Special Operations Command Research, Development, and Acquisition Center to further develop military applications for the company's real-time PCR pathogen detection system, Firefly Dx.

NEW YORK (GenomeWeb) — PositiveID and Ensco have been awarded a SenseNet Program contract for an undisclosed amount from the US Department of the Interior on behalf of the US Department of Homeland Security Science and Technology Directorate, Positive ID said today.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

NEW YORK (GenomeWeb) — Biodetection and biodefense company PositiveID recently announced a number of research awards and partnerships, including with the US Defense Threat Reduction Agency and NASA, which it is using to develop its handheld microfluidic PCR device, called Firefly Dx, for governme

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.